Diem Nguyen's most recent trade in Candel Therapeutics Inc was a trade of 14,240 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Verrica Pharmaceuticals Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 255,137 | 255,137 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 55,902 | 91,297 (0%) | 0% | 0 | Common Stock, par value $.0001 per share | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 55,902 | 111,805 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.34 per share. | 27 Jan 2025 | 23,644 | 67,653 (0%) | 0% | 6.3 | 149,903 | Common Stock, par value $.0001 per share |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 59,288 | 118,577 | - | - | Performance Stock Units | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 59,288 | 59,288 (0%) | 0% | 0 | Common Stock, par value $.0001 per share | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.77 per share. | 25 Oct 2024 | 23,893 | 35,395 (0%) | 0% | 6.8 | 161,756 | Common Stock, par value $.0001 per share |
| Candel Therapeutics Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Verrica Pharmaceuticals Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2024 | 219,212 | 219,212 | - | - | Stock Option (Right to buy) | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2024 | 177,865 | 177,865 | - | - | Performance Stock Units | |
| SIGA Technologies Inc | Diem Nguyen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2024 | 167,707 | 167,707 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Nguyen Diem | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2024 | 109,606 | 109,606 | - | - | Stock Option (Right to buy) | |
| Candel Therapeutics Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Verrica Pharmaceuticals Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 10,384 | 10,384 | - | - | Stock Option (right to buy) | |
| Candel Therapeutics Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Verrica Pharmaceuticals Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 10,384 | 10,384 | - | - | Stock Option (right to buy) | |
| Candel Therapeutics Inc | Diem Nguyen | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 10,000 | 10,000 | - | 8 | 80,000 | Common Stock |
| Verrica Pharmaceuticals Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 8,109 | 8,109 | - | - | Stock Option (right to buy) |